| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $328.1M | -19.7% |
| Cost of Revenue | $44.3M | -12.5% |
| R&D Expense | $8.8M | -11.0% |
| SG&A Expense | $78.3M | -13.7% |
| Operating Income | $62.6M | -29.7% |
| Pre-tax Income | $66.6M | -30.9% |
| Income Tax | $2.6M | -21.4% |
| Net Income | $5.6M | -20.4% |
| EPS (Basic) | $2.41 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $70.1M | -28.3% |
| Accounts Receivable | $5.7M | +205.0% |
| Current Assets | $131.7M | -22.0% |
| Total Assets | $218.4M | -15.9% |
| Current Liabilities | $234.2M | -10.0% |
| Total Liabilities | $432.0M | -9.5% |
| Stockholders' Equity | -$11.7M | +6.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $46.0M | +307.5% |
| Capital Expenditures | $391K | +194.0% |
| Investing Cash Flow | -$1.6M | -130.1% |
| Financing Cash Flow | -$72.1M | -109.3% |
| Free Cash Flow | $45.6M | +304.5% |
| +1238.9% |
| EPS (Diluted) | $2.31 | +1183.3% |